Overdiagnosis and overtreatment of prostate cancer

…, J Nicholson, TL Tammela, DF Penson, HB Carter… - European urology, 2014 - Elsevier
Context Although prostate cancer (PCa) screening reduces the incidence of advanced disease
and mortality, trade-offs include overdiagnosis and resultant overtreatment. Objective To …

Active surveillance for prostate cancer: a systematic review of the literature

…, PC Albertsen, C Bangma, PR Carroll, HB Carter… - European urology, 2012 - Elsevier
CONTEXT: Prostate cancer (PCa) remains an increasingly common malignancy worldwide.
The optimal management of clinically localized, early-stage disease remains unknown, and …

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings

…, JL Cox, H Rittenhouse, R Wolfert, HB Carter - The Journal of …, 1998 - auajournals.org
Purpose : Approximately 25% of radical prostatectomies performed for stage T1c disease
show potentially insignificant prostate cancer. We previously reported the use of serum …

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan… - Jama, 1992 - jamanetwork.com
Objective. ——To evaluate longitudinal changes in prostate-specific antigen (PSA) levels in
men with and without prostate disease. Design. —Case-control study of men with and …

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan… - The Journal of …, 1993 - Elsevier
Clinical stage, Gleason score and serum prostate specific antigen (PSA) levels are used
separately to predict pathological stage in patients with localized prostate cancer. Because the …

Early detection of prostate cancer: AUA Guideline

HB Carter, PC Albertsen, MJ Barry, R Etzioni… - The Journal of …, 2013 - auajournals.org
Purpose : The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods : A …

The prostate: an increasing medical problem

H Ballentine Carter, DS Coffey - The prostate, 1990 - Wiley Online Library
The prostate gland is the major site of medical problems in the US male. Surgery for benign
prostatic hyperplasia is the most common surgical procedure performed in males, and the …

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia

AW Partin, HB Carter, DW Chan, JI Epstein… - The Journal of …, 1990 - Elsevier
To evaluate the usefulness of serum prostate specific antigen in the preoperative staging of
prostate cancer we examined tumor volume and differentiation, as well as benign prostatic …

Complications after prostate biopsy: data from SEER-Medicare

S Loeb, HB Carter, SI Berndt, W Ricker… - The Journal of …, 2011 - auajournals.org
Purpose : More than 1 million prostate biopsies are performed annually among Medicare
beneficiaries. We determined the risk of serious complications requiring hospitalization. We …

[PDF][PDF] Active surveillance program for prostate cancer: an update of the Johns Hopkins experience

…, Z Feng, JI Epstein, AW Partin, PC Walsh, HB Carter - J Clin …, 2011 - researchgate.net
Results The median survival free of intervention was 6.5 years (range, 0.0 to 15.0 years)
after diagnosis, and the proportions of men remaining free of intervention after 2, 5, and 10 …